Abstract
ObjectiveIvabradine, a specific heart rate lowering therapy, has been shown in a randomised placebo-controlled study, Systolic HF Treatment with the If Inhibitor Ivabradine Trial (SHIfT), to significantly reduce the composite...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have